CAR-T cells chimeric antigen receptor T cells
IIT2025144
Phase 1 small_molecule active
Quick answer
CAR-T cells chimeric antigen receptor T cells for Relapsed/Refractory Acute Myeloid Leukemia(AML) is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Relapsed/Refractory Acute Myeloid Leukemia(AML)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active